IL99429A0 - Peptide inhibitors of lymphocyte response and immune-related diseases - Google Patents
Peptide inhibitors of lymphocyte response and immune-related diseasesInfo
- Publication number
- IL99429A0 IL99429A0 IL99429A IL9942991A IL99429A0 IL 99429 A0 IL99429 A0 IL 99429A0 IL 99429 A IL99429 A IL 99429A IL 9942991 A IL9942991 A IL 9942991A IL 99429 A0 IL99429 A0 IL 99429A0
- Authority
- IL
- Israel
- Prior art keywords
- immune
- related diseases
- peptide inhibitors
- lymphocyte response
- lymphocyte
- Prior art date
Links
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 210000004698 lymphocyte Anatomy 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4703—Inhibitors; Suppressors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Transplantation (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US57850690A | 1990-09-06 | 1990-09-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL99429A0 true IL99429A0 (en) | 1992-08-18 |
Family
ID=24313172
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL99429A IL99429A0 (en) | 1990-09-06 | 1991-09-06 | Peptide inhibitors of lymphocyte response and immune-related diseases |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP0503055A1 (https=) |
| JP (1) | JPH05507501A (https=) |
| AU (1) | AU650065B2 (https=) |
| CA (1) | CA2071896A1 (https=) |
| IL (1) | IL99429A0 (https=) |
| NZ (1) | NZ239699A (https=) |
| WO (1) | WO1992004049A1 (https=) |
| ZA (1) | ZA917097B (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ266739A (en) * | 1993-06-02 | 1997-07-27 | Tvw Telethon Inst Child Health | Inducing immunologic tolerance by administering a cryptic peptide derived from the antigen der pi |
| CA2185826C (en) * | 1994-03-21 | 2007-06-19 | Stephen Mark Anderton | Peptide fragments of microbial stress proteins and pharmaceutical composition made thereof for the treatment and prevention of inflammatory diseases |
| GB9419553D0 (en) * | 1994-09-27 | 1994-11-16 | Univ Bristol | Polypeptides and their use in the treatment of auto-immune disease |
| IT1271074B (it) * | 1994-11-21 | 1997-05-26 | Italfarmaco Spa | Peptidi ad attivita' antiinfiammatoria |
| US6338852B1 (en) | 1995-09-01 | 2002-01-15 | Corixa Corporation | Compounds and methods for diagnosis of tuberculosis |
| US6290969B1 (en) | 1995-09-01 | 2001-09-18 | Corixa Corporation | Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| US6592877B1 (en) | 1995-09-01 | 2003-07-15 | Corixa Corporation | Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| US6458366B1 (en) | 1995-09-01 | 2002-10-01 | Corixa Corporation | Compounds and methods for diagnosis of tuberculosis |
| US5993803A (en) * | 1996-08-30 | 1999-11-30 | Yeda Research And Development Co., Ltd. | Method of reducing the severity of host vs graft reaction by down-regulating hsp60 autoimmunity |
| KR20000070460A (ko) * | 1997-01-24 | 2000-11-25 | 왈리스 조 앤 | 메토트렉세이트와 공동으로 내성화를 사용한 자기면역질병의 치료 |
| US6465633B1 (en) | 1998-12-24 | 2002-10-15 | Corixa Corporation | Compositions and methods of their use in the treatment, prevention and diagnosis of tuberculosis |
| ES2526822T3 (es) | 2002-01-31 | 2015-01-15 | Andromeda Bio Tech Ltd. | Péptidos hsp y análogos para la modulación de respuestas inmunes mediante células presentadoras de antígeno |
| EP2301566B1 (en) | 2002-05-21 | 2013-07-03 | Irun R. Cohen | DNA vaccines encoding heat shock proteins |
| WO2006072946A2 (en) | 2005-01-04 | 2006-07-13 | Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science | Hsp60, hsp60 peptides and t cell vaccines for immunomodulation |
-
1991
- 1991-09-05 JP JP91517849A patent/JPH05507501A/ja active Pending
- 1991-09-05 WO PCT/US1991/006434 patent/WO1992004049A1/en not_active Ceased
- 1991-09-05 EP EP91918631A patent/EP0503055A1/en not_active Withdrawn
- 1991-09-05 CA CA002071896A patent/CA2071896A1/en not_active Abandoned
- 1991-09-05 AU AU87559/91A patent/AU650065B2/en not_active Expired - Fee Related
- 1991-09-06 ZA ZA917097A patent/ZA917097B/xx unknown
- 1991-09-06 NZ NZ239699A patent/NZ239699A/en unknown
- 1991-09-06 IL IL99429A patent/IL99429A0/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2071896A1 (en) | 1992-03-07 |
| EP0503055A4 (https=) | 1994-02-16 |
| NZ239699A (en) | 1993-11-25 |
| ZA917097B (en) | 1992-09-30 |
| JPH05507501A (ja) | 1993-10-28 |
| WO1992004049A1 (en) | 1992-03-19 |
| AU8755991A (en) | 1992-03-30 |
| AU650065B2 (en) | 1994-06-09 |
| EP0503055A1 (en) | 1992-09-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR970009081B1 (en) | Vectors and compounds for direct expression of activated human protein c | |
| EP0785276A4 (en) | MODIFICATION OF A PEPTIDE AND A PROTEIN | |
| IL108079A0 (en) | Modified hydrolyzed vegetable protein microspheres and methods for preparation and use thereof | |
| ZA967654B (en) | Electrodes and methods of preparation thereof | |
| IL99429A0 (en) | Peptide inhibitors of lymphocyte response and immune-related diseases | |
| IL115015A0 (en) | Methods of inhibiting demyelinating and desmyelinating diseases | |
| KR890700602A (ko) | 면역억제성 펩타이드 및 사용방법 | |
| IL97310A0 (en) | Vectors and compounds for expression of zymogen forms of human protein c | |
| HU893412D0 (en) | Inhibitors of interleucin-1 | |
| EP0450598A3 (en) | Inhibitors of the advanced glycosylation of proteins and methods of use therefor | |
| CS135591A2 (en) | Method of peptide preparation | |
| EP0786001A4 (en) | CHEMOKIN-LIKE PROTEINS AND THEIR USE | |
| JPS6450900A (en) | Carboxamide derivative of glycopeptide | |
| DE3268774D1 (en) | Isolation of protein and peptide from urine | |
| GB2280439B (en) | CD4 binding agents and inhibitors of collagenase and protein kinase C | |
| AU1719988A (en) | Aminopeptidase for removing n-terminal methionine from proteins and proteins prepared therefrom | |
| NO952261D0 (no) | Antacidiumforbindelser og fremgangsmåte for fremstilling derav | |
| ZA912183B (en) | Protein phosphatase inhibitor-1 gene and expression | |
| GB9405905D0 (en) | Inhibitors of isoprenylated protein endoprotease | |
| EP0354819A3 (en) | Novel peptide and anti-dementia agent | |
| AU4527389A (en) | Amino acid and peptide inhibitors of human leukocytic elastase and collagenase | |
| GB8802858D0 (en) | Detection of protein | |
| JPS6490196A (en) | Inhibitor peptide i and ii | |
| AU8939691A (en) | Peptide inhibitors of neutrophil activation proteins | |
| ZA896146B (en) | Novel peptide and anti-dementia agent |